Skip to content

Spatially Transcriptomics Reveals Molecular Signatures in CRPS

Spatially Resolved Transcriptomics Reveals Phenotype-specific Molecular Signatures in Complex Regional Pain Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05986461
Enrollment
10
Registered
2023-08-14
Start date
2023-07-18
Completion date
2024-12-31
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regional Pain Syndromes

Brief summary

This observational study aims to understand phenotype-specific molecular signatures in patients with complex regional pain syndrome (CRPS).

Detailed description

Participants who meet the diagnostic criteria for CRPS, aged 19\ 80 years, and agree to participate in this study will undergo a 4mm-sized skin punch biopsy in the involved limb, as well as the contralateral side (internal control). Spatial transcriptomics will be used to identify immune cell signatures and differentially regulated genes (DEGs) in the epidermis, vasculature, sweat gland, and nerve plexus of the involved ipsilateral (vs contralateral) side of the patient's skin.

Interventions

None listed

Sponsors

Hanyang University
CollaboratorOTHER
Seoul National University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Meets the Budapest diagnostic criteria * Consents to participation in this study * Aged between 19 and 80 years old * Symptoms and/or signs of sensory, vasomotor, and sudomotor changes

Exclusion criteria

* Who do not agree to participate in this study * Who has contraindications for skin punch biopsy (e.g. thrombocytopenia, taking anticoagulant drugs)

Design outcomes

Primary

MeasureTime frameDescription
Numerical Rating Scale (NRS)At the time of biopsyIntensity of pain (now, weekly avarege, weekly maximum)
ThermographyAt the time of diagnosisThermography of the involved limb
Quantitative Sensory Testing (QST)At the time of diagnosisVibration Detection Threshold (VDT), Cold Detection Threshold (CDT)

Countries

South Korea

Contacts

Primary ContactJee Youn Moon, MD, PhD
jymoon0901@gmail.com82-10-5299-2036
Backup ContactJeongsoo Kim, MD
dreamsu457@gmail.com82-10-4734-6422

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026